Skip to main content
. 2019 Nov 26;19(1):710–716. doi: 10.3892/etm.2019.8247

Table I.

Comparison of baseline data of patients between the two groups [n(%), mean ± SD].

Category CG (n=50) SG (n=60) χ2/t value P-value
Age/years 3.976 0.046
  ≥35 7 (14.00) 18 (28.33)
  <35 43 (86.00) 42 (71.67)
Diabetes history 13.943 0.002
  Yes 8 (16.00) 30 (50.00)
  No 42 (84.00) 30 (50.00)
Hyperlipidemia 4.125 0.042
  Yes 5 (10.00) 15 (25.00)
  No 45 (90.00) 45 (75.00)
Height (cm) 161.54±5.23 162.01±5.12 0.637 0.526
Pre-pregnancy BMI (kg/m2) 4.073 0.044
  ≥23 11 (26.00) 24 (35.00)
  <23 39 (74.00) 36 (65.00)
Increase of body mass during pregnancy (kg) 13.52±4.26 15.61±4.53 2.475 0.015
Gestational age (week) 23.85±1.85 24.45±1.55 1.851 0.067
Abdominal circumference (cm) 99.98±6.36 101.87±6.65 1.514 0.133
Systolic blood pressure (mmHg) 114.12±9.06 115.59±8.99 0.851 0.397
Diastolic blood pressure (mmHg) 72.98±7.16 75.04±6.88 1.535 0.128
Fasting blood glucose (mmol/l) 4.58±0.35 6.13±0.89 11.580 <0.001
Fasting insulin (mU/l) 9.12±4.67 13.19±5.15 4.304 <0.001
Postprandial insulin for 0.5 h (mU/l) 71.39±37.85 67.88±24.05 0.590 0.557
Postprandial insulin for 1 h (mU/l) 90.87±34.58 83.81±23.66 1.266 0.208
Postprandial insulin for 2 h (mU/l) 70.27±22.64 80.85±36.09 1.798 0.075
HOMA-IR 6.42±1.81 22.35±13.88 8.053 <0.001
Total cholesterol (mmol/l) 5.92±1.43 6.03±1.28 0.426 0.671
Chemerin (µg/l) 5.78±1.35 7.71±2.23 5.354 <0.001
FABP4 (µg/l) 21.53±8.89 35.14±11.39 6.880 <0.001

FABP4, fatty acid-binding protein 4; SG, study group; CG, control group.